Company Anavex Life Sciences Corp OTC Bulletin Board
Equities
AVXL
US0327971026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
01/07 | Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell Small Cap Comp Value Index | CI |
01/07 | Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell 2500 Value Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 01/15/01 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 02/19/02 |
David Goldberger
LAW | General Counsel | - | 06/11 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 05/21/05 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 01/15/01 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Tom Skarpelos
FOU | Founder | 57 | 23/04/23 |
Jiong Ma
CHM | Chairman | 60 | 25/21/25 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15/15/15 |
Peter Donhauser
BRD | Director/Board Member | 58 | 08/17/08 |
Director/Board Member | 51 | 02/18/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,641,537 | 82,056,906 ( 96.95 %) | 0 | 96.95 % |
Company contact information
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.com![address Anavex Life Sciences Corp(AVXL)](https://cdn.zonebourse.com/static/address/223946.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.17% | 13TCr | |
+24.67% | 12TCr | |
+25.44% | 2.77TCr | |
-17.74% | 2.03TCr | |
-15.17% | 1.68TCr | |
-15.21% | 1.56TCr | |
+11.91% | 1.48TCr | |
-47.10% | 1.46TCr | |
+54.50% | 1.44TCr |
- Stock Market
- Equities
- AVXL Stock
- AVXL Stock
- Company Anavex Life Sciences Corp